{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3D model", "Apigenin", "Blood endothelial disintegration", "CRC spheroids", "Drug-resistance", "FDA approved drugs"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29129665", "DateCompleted": {"Year": "2018", "Month": "05", "Day": "01"}, "DateRevised": {"Year": "2018", "Month": "05", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "11", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1016/j.fct.2017.11.015", "S0278-6915(17)30673-7"], "Journal": {"ISSN": "1873-6351", "JournalIssue": {"Volume": "111", "PubDate": {"Year": "2018", "Month": "Jan"}}, "Title": "Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association", "ISOAbbreviation": "Food Chem Toxicol"}, "ArticleTitle": "Intravasation of SW620 colon cancer cell spheroids through the blood endothelial barrier is inhibited by clinical drugs and flavonoids in vitro.", "Pagination": {"StartPage": "114", "EndPage": "124", "MedlinePgn": "114-124"}, "Abstract": {"AbstractText": ["Mechanisms how colorectal cancer (CRC) cells penetrate blood micro-vessel endothelia and metastasise is poorly understood. To study blood endothelial cell (BEC) barrier breaching by CRC emboli, an in vitro assay measuring BEC-free areas underneath SW620\u00a0cell spheroids, so called \"circular chemorepellent induced defects\" (CCIDs, appearing in consequence of endothelial retraction), was adapted and supported by Western blotting, EIA-, EROD- and luciferase reporter assays. Inhibition of ALOX12 or NF-\u03baB in SW620\u00a0cells or BECs, respectively, caused attenuation of CCIDs. The FDA approved drugs vinpocetine [inhibiting ALOX12-dependent 12(S)-HETE synthesis], ketotifen [inhibiting NF-\u03baB], carbamazepine and fenofibrate [inhibiting 12(S)-HETE and NF-\u03baB] significantly attenuated CCID formation at low \u03bcM concentrations. In the 5-FU-resistant SW620-R/BEC model guanfacine, nifedipine and proadifen inhibited CCIDs stronger than in the na\u00efve SW620/BEC model. This indicated that in SW620-R cells formerly silent (yet unidentified) genes became expressed and targetable by these drugs in course of resistance acquisition. Fenofibrate, and the flavonoids hispidulin and apigenin, which are present in medicinal plants, spices, herbs and fruits, attenuated CCID formation in both, na\u00efve- and resistant models. As FDA-approved drugs and food-flavonoids inhibited established and acquired intravasative pathways and attenuated BEC barrier-breaching in vitro, this warrants testing of these compounds in CRC models in vivo."], "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Holzner", "ForeName": "Silvio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy and Diagnostics, University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Brenner", "ForeName": "Stefan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Atanasov", "ForeName": "Atanas Georgiev", "Initials": "AG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Senfter", "ForeName": "Daniel", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Stadler", "ForeName": "Serena", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Nguyen", "ForeName": "Chi Huu", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria; Department of Clinical Pharmacy and Diagnostics, University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Fristiohady", "ForeName": "Adryan", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Milovanovic", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Huttary", "ForeName": "Nicole", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Krieger", "ForeName": "Sigurd", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria."}], "LastName": "Bago-Horvath", "ForeName": "Zsuzsanna", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiation Oncology and Experimental Cancer Research, Ghent University, Ghent B-9000, Belgium."}], "LastName": "de Wever", "ForeName": "Oliver", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Medical School, Democritus University of Thrace, 681 00 Dragana/Alexandroupolis, Greece."}], "LastName": "Tentes", "ForeName": "Ioannis", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Adnan Menderes University, Faculty of Science and Art, Department of Biology, 09010 Aydin, Turkey."}], "LastName": "\u00d6zmen", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy and Diagnostics, University of Vienna, A-1090 Vienna, Austria."}], "LastName": "J\u00e4ger", "ForeName": "Walter", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Genetics, Medical University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Dolznig", "ForeName": "Helmut", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Dirsch", "ForeName": "Verena Maria", "Initials": "VM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine I, Comprehensive Cancer Center of the Medical University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Mader", "ForeName": "Robert Michael", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria."}], "LastName": "Krenn", "ForeName": "Liselotte", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Institute of Pathology, Medical University of Vienna, Austria. Electronic address: georg.krupitza@meduniwien.ac.at."}], "LastName": "Krupitza", "ForeName": "Georg", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Food Chem Toxicol", "NlmUniqueID": "8207483", "ISSNLinking": "0278-6915"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Calcium Channel Blockers"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}, {"RegistryNumber": "EC 1.13.11.31", "NameOfSubstance": "Arachidonate 12-Lipoxygenase"}, {"RegistryNumber": "EC 1.13.11.31.", "NameOfSubstance": "ALOX12 protein, human"}], "MeshHeadingList": [{"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Arachidonate 12-Lipoxygenase"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Calcium Channel Blockers"}, {"QualifierName": ["pathology"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": ["physiology"], "DescriptorName": "Endothelial Cells"}, {"QualifierName": ["physiology"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": [], "DescriptorName": "Pharmaceutical Preparations"}, {"QualifierName": ["physiology"], "DescriptorName": "Spheroids, Cellular"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "9", "Day": "5"}, {"Year": "2017", "Month": "11", "Day": "6"}, {"Year": "2017", "Month": "11", "Day": "8"}, {"Year": "2017", "Month": "11", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "14", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29129665", "10.1016/j.fct.2017.11.015", "S0278-6915(17)30673-7"]}}]}